- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jenburkt Pharmaceuticals Ltd — Board Meeting, 03-02-2026: Board Meeting
03-02-2026 | 05:15 pm
03-02-2026 | 05:15 pm
Jenburkt Pharma's Board approved Q3 & 9M FY25 financial results. Q3 revenue was ₹43.02 Cr, PAT ₹5.93 Cr (EPS ₹13.44). For 9 months, revenue hit ₹124.11 Cr, PAT ₹23.89 Cr (EPS ₹54.12). Figures reviewed by Audit Committee.
No comments yet. Be the first to comment!